Perspective Therapeutics, Inc. (CATX)
3.18
-0.12
(-3.64%)
USD |
NYAM |
Aug 24, 16:00
3.18
0.00 (0.00%)
After-Hours: 20:00
Perspective Therapeutics Total Assets (Quarterly) : 392.02M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 392.02M |
| March 31, 2026 | 410.77M |
| December 31, 2025 | 274.34M |
| September 30, 2025 | 294.82M |
| June 30, 2025 | 310.72M |
| March 31, 2025 | 329.35M |
| December 31, 2024 | 350.10M |
| September 30, 2024 | 391.15M |
| June 30, 2024 | 385.92M |
| March 31, 2024 | 278.29M |
| December 31, 2023 | |
| September 30, 2023 | 110.52M |
| June 30, 2023 | 120.14M |
| March 31, 2023 | 127.64M |
| June 30, 2022 | 64.44M |
| March 31, 2022 | 66.11M |
| December 31, 2021 | 67.25M |
| September 30, 2021 | 68.71M |
| June 30, 2021 | 70.42M |
| March 31, 2021 | 71.28M |
| December 31, 2020 | 15.51M |
| September 30, 2020 | 8.025M |
| June 30, 2020 | 8.699M |
| March 31, 2020 | 8.962M |
| December 31, 2019 | 8.933M |
| Date | Value |
|---|---|
| September 30, 2019 | 10.12M |
| June 30, 2019 | 9.422M |
| March 31, 2019 | 10.58M |
| December 31, 2018 | 11.91M |
| September 30, 2018 | 13.34M |
| June 30, 2018 | 7.455M |
| March 31, 2018 | 8.322M |
| December 31, 2017 | 9.378M |
| September 30, 2017 | 10.78M |
| June 30, 2017 | 12.27M |
| March 31, 2017 | 13.94M |
| December 31, 2016 | 14.98M |
| September 30, 2016 | 16.68M |
| June 30, 2016 | 18.10M |
| March 31, 2016 | 19.80M |
| December 31, 2015 | 20.74M |
| September 30, 2015 | 21.91M |
| June 30, 2015 | 23.00M |
| March 31, 2015 | 23.58M |
| December 31, 2014 | 24.59M |
| September 30, 2014 | 25.54M |
| June 30, 2014 | 26.55M |
| March 31, 2014 | 27.20M |
| December 31, 2013 | 8.188M |
| September 30, 2013 | 9.335M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 183.47M |
| MiMedx Group, Inc. | 281.00M |
| ABVC BioPharma, Inc. | 19.40M |
| Enovis Corp. | 3.766B |
| Edwards Lifesciences Corp. | 13.87B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 68.16M |
| Shareholders Equity (Quarterly) | 323.86M |
| Debt to Equity Ratio | 0.0122 |
| Current Ratio | 6.609 |
| Net Debt Paydown Yield | -0.01% |